01718nam 2200445 450 991071156390332120190307141534.0(CKB)5470000002484411(OCoLC)1060613993(EXLCZ)99547000000248441120181102d2018 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierThe administration's FDA reforms and reduced biopharmaceutical drug prices /The Council of Economic Advisers[Washington, D.C.] :Executive Office of the President of the United States, Council of Economic Advisers,2018.1 online resource (17 pages) color illustrations"October 2018."Includes bibliographical references (pages 15-17).Administration's Food and Drug Administration reforms and reduced biopharmaceutical drug pricesDrugsUnited StatesCostsDrug approvalUnited StatesGeneric drugsGovernment policyUnited StatesDrug developmentUnited StatesPharmaceutical industryDeregulationUnited StatesCompetitionGovernment policyUnited StatesDrugsCosts.Drug approvalGeneric drugsGovernment policyDrug developmentPharmaceutical industryDeregulationCompetitionGovernment policyGPOGPOBOOK9910711563903321The administration's FDA reforms and reduced biopharmaceutical drug prices3474058UNINA